P16(INK4A) is required for cisplatin resistance in cervical carcinoma SiHa cells

Cervical cancer is the third most commonly diagnosed cancer worldwide and the fourth leading cause of cancer-related mortality in females worldwide, accounting for 10–15% of cancer-related mortalities. Cytological screening and DNA testing for high-risk human papillomavirus (HPV) types have markedly...

Descripción completa

Detalles Bibliográficos
Autores principales: LI, YUERAN, XIAO, SONGSHU, DAN, LIU, XUE, MIN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315085/
https://www.ncbi.nlm.nih.gov/pubmed/25663864
http://dx.doi.org/10.3892/ol.2014.2814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315085/
https://www.ncbi.nlm.nih.gov/pubmed/25663864
http://dx.doi.org/10.3892/ol.2014.2814

Ejemplares similares